VolitionRX Limited

VNRX
0,829
0,0191 (2,36%)
11 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202414:00PRNUSVolitionRx Limited Schedules First Quarter 2024 Earnings..
23/4/202414:00PRNUSNu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe..
26/3/202412:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
25/3/202421:10PRNUSVolitionRx Limited Announces Full Fiscal Year 2023 Financial..
21/3/202413:30PRNUSVolitionRx Limited Schedules Fourth Quarter and Full Year..
20/3/202413:30PRNUSVolition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer..
19/3/202421:30PRNUSVolition appoints Dr Andrew Retter as Chief Medical Officer
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202421:56EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202414:00PRNUSVolition to Share Nu.Q® NETs Strategy Update at Upcoming..
26/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202414:00PRNUSVolition Issues Business Review 2023
03/1/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:00EDGAR2Form 8-K - Current report
20/12/202316:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202314:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202314:07EDGAR2Form 8-K - Current report
05/12/202314:00PRNUSVolitionRx Secures Approximately $5.5 Million in Belgium..
28/11/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202315:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202316:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/11/202317:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202322:10PRNUSVolitionRx Limited Announces Third Quarter 2023 Financial..
08/11/202314:00PRNUSVolitionRx Limited Schedules Third Quarter 2023 Earnings..
06/11/202312:24PRNUSVolition and VPG Launch Nu.Q® Vet Cancer Test in UK &..
06/11/202312:21PRNUSVolition and VPG Launch Nu.Q® Vet Cancer Test in UK &..
23/10/202314:00PRNUSVolition Presents Breakthrough Liquid Biopsy Blood Test..
20/10/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,8115 Min: 0,789 Max: 0,8227
Chiusura: 0,8099

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network